0.77 USD
↘ 0.06 (6.87%)LIVE (AS OF 01:32 PM EDT)
NeuroSense Therapeutics Ltd. Ordinary Shares
NRSNNASDAQ • USD
Market: OPEN
Open?$0.84
High?$0.87
Low?$0.74
Prev. Close?$0.83
Volume?263.7K
Avg. Volume?N/A
VWAP?$0.80
Bid / Ask
Bid?$0.67 × 100
Ask?$0.90 × 100
Spread?$0.23
Midpoint?$0.79
Valuation & Ratios
Market Cap?27.7M
Shares Out?32.6M
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Related Companies
Loading...
News
Profile
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.